Suchergebnisse - "Khani, Elnaz"

PubPharm (15)

1

New-onset systemic lupus erythematosus after BBIBP-CorV vaccination

enthalten in: Clinical case reports | 2024

von Pourkarim, F. | Khani, E. | Ghadakchi, L. | +1

2

Effects of citalopram on blood pressure control in depressive patients with hypertension : A randomized clinical trial

enthalten in: Journal of cardiovascular and thoracic research | 2024

von Namdar, H. | Khani, E. | Khiali, S. | +4

3

Effects of Triamterene in Hospitalized Patients with Heart Failure and Diuretic Resistance : A Randomized Clinical Trial

enthalten in: Journal of clinical pharmacology | 2023

von Taban-Sadeghi, M. | Khani, E. | Khezripour, K. | +3

4

Monkeypox treatment : Current evidence and future perspectives

enthalten in: Journal of medical virology | 2023

von Khani, E. | Afsharirad, B. | Entezari-Maleki, T.

CommentIn: J Med Virol. 2023 May;95(5):e28798. - PMID 37212328

5

Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'

enthalten in: International journal of surgery (London, England) | 2023

von Khani, E. | Entezari-Maleki, T.

CommentOn: Int J Surg. 2022 Aug;104:106806. - PMID 35926828

6

A commentary on "Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies : Another potential global threat?" (Int J Surg 2022;103:106705)

enthalten in: International journal of surgery (London, England) | 2022

von Khani, E. | Entezari-Maleki, T.

CommentOn: Int J Surg. 2022 Jul;103:106705. - PMID 35697322

7

Current evidence on the use of anakinra in COVID-19

enthalten in: International immunopharmacology | 2022

von Khani, E. | Shahrabi, M. | Rezaei, H. | +3

8

Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists

enthalten in: Molecular psychiatry | 2022

von Khani, E. | Entezari-Maleki, T.

CommentOn: Mol Psychiatry. 2022 Apr;27(4):1898-1907. - PMID 34997196

9

Hypertensive Crisis Following COVID-19 Vaccination

enthalten in: Journal of clinical pharmacology | 2022

von Khani, E. | Entezari-Maleki, T.

CommentOn: Hypertension. 2021 Jun;77(6):e56-e57. - PMID 33764160

10

Comprehensive review on molnupiravir in COVID-19 : a novel promising antiviral to combat the pandemic

enthalten in: Future microbiology | 2022

von Khiali, S. | Khani, E. | B Rouy, S. | +1